Ming-Ju Chen

Title: Innovations of Ming-Ju Chen in Probiotic Research

Introduction

Ming-Ju Chen is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of probiotic research, holding a total of 2 patents. His work focuses on developing innovative probiotic compositions that have potential applications in treating various health conditions.

Latest Patents

Ming-Ju Chen's latest patents include groundbreaking inventions related to probiotic compositions. One of his notable patents involves an isolated bacterial strain of subsp. MFM 30-3, which is deposited under the DSMZ Accession No. DSM 34213. This patent describes a probiotic composition that includes the subsp. MFM 30-3 and optionally one or more additional probiotic organisms that enhance its activity. Furthermore, it outlines a method for preventing or treating chronic kidney disease by administering a pharmaceutically effective amount of this probiotic composition. Another patent focuses on a strain that can be used for treating metabolic syndrome, providing methods for treating obesity, diabetes, or complications arising from diabetes.

Career Highlights

Ming-Ju Chen is affiliated with National Taiwan University, where he continues to advance his research in probiotics. His work has garnered attention for its potential to improve health outcomes through innovative probiotic solutions.

Collaborations

Ming-Ju Chen collaborates with esteemed colleagues, including Hsiao-Wen Huang and Yu-chun Lin, to further enhance the impact of his research in the field of probiotics.

Conclusion

Ming-Ju Chen's contributions to probiotic research exemplify the importance of innovation in healthcare. His patents reflect a commitment to developing effective solutions for chronic health issues.